register free | resend password

DGAP-News: Raptor Pharmaceutical Corp. to Present at Two Upcoming Investor Conferences

ID: 1139814
recent pressrelease next pressrelease

(businesspress24) - Raptor Pharmaceutical Corp.

07.08.2012 12:30

NOVATO, Calif., 2012-08-07 12:30 CEST (GLOBE NEWSWIRE) --
Raptor Pharmaceutical Corp. ('Raptor' or the 'Company') (Nasdaq:RPTP), today
announced that Ted Daley, President of Raptor, will present an overview of the
Company at two investor conferences in August.

The conference presentation schedule is as follows:

Canaccord Genuity Annual Growth Conference
August 14, 2012 at 10:00am ET
InterContinental, Boston, MA

Wedbush PACGROW LIFE SCIENCES Management Access Conference
August 15, 2012 at 1:55pm ET
Le Parker Meridien, New York, NY

A live audio webcast and 14-day archive of the Canaccord and Wedbush
presentations will be available at

About Raptor Pharmaceutical Corp.

Raptor Pharmaceutical Corp. (Nasdaq:RPTP) ('Raptor') seeks to research,
produce, and deliver medicines that improve life for patients with severe, rare
disorders. Raptor currently has product candidates in clinical development to
potentially treat nephropathic cystinosis, Non-alcoholic Steatohepatitis
('NASH'), Huntington's Disease ('HD'), aldehyde dehydrogenase deficiency
('ALDH2'), and thrombotic disorder.

Raptor's preclinical programs are based upon bioengineered novel drug
candidates and drug-targeting platforms derived from the human
receptor-associated protein and related proteins that are designed to target
cancer and infectious diseases.

For additional information, please visit

The Raptor Pharmaceutical Corp. logo is available at

CONTACT: Trout Group (investors)
Lauren Glaser
(646) 378-2972

EVC Group (media)
Janine McCargo
(646) 688-0425
News Source: NASDAQ OMX

07.08.2012 Dissemination of a Corporate News, transmitted by DGAP -
a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at and


Language: English
Company: Raptor Pharmaceutical Corp.

United States
ISIN: US75382F1066

End of Announcement DGAP News-Service


Keywords (optional):


Company information / Profile:

PressRelease by


PressContact / Agency:

published by: EquityStory
print pressrelease  send to a friend  

Date: 08/07/2012 - 12:30
Language: English
News-ID 1139814
Character count: 0
Firma: Raptor Pharmaceutical Corp.
Ansprechpartner: Feedback to about Pressrelease-id:


Number of hits: 154


Direct Link to this PressRelease:

We would appreciate a link in your News-, Press- or Partner-Site.

Comments on this PressRelease

All members: 9 437
Register today: 0
Register yesterday: 0
Members online: 0
Guests online: 129

Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.